- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.08. | FLUENT GAAP EPS of -$0.02, revenue of $17.1M | 1 | Seeking Alpha | ||
| 22.08. | FLUENT Corp: FLUENT Reports Second Quarter 2026 Results | 308 | GlobeNewswire (Europe) | Q2 2026 Revenue brought in $17.1MEnded quarter with $4.5 million of cash and cash equivalentsNew Interim CEO appointed TAMPA, Fla., Aug. 21, 2026 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB:... ► Artikel lesen | |
| 29.07. | FLUENT Corp: FLUENT Announces Shareholder Approval of All-Stock Transaction with Vireo Growth | 515 | GlobeNewswire (Europe) | TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- FLUENT Corp. ("FLUENT") (CSE: FNT.U) (OTCQB: CNTMF), a vertically-integrated, multi-state cannabis company, is pleased to announce that at its annual general... ► Artikel lesen | |
| 24.07. | Fluent Corp: Fluent receives exemptive relief related to AGM | 2 | Stockwatch | ||
| FLUENT CORP Aktie jetzt für 0€ handeln | |||||
| 24.07. | FLUENT Corp: Fluent Announces Receipt of Exemptive Relief Relating to Annual General and Special Meeting; Extension of Proxy Deposit Deadline | 203 | GlobeNewswire (Europe) | TORONTO, July 23, 2026 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, announces that, further to its... ► Artikel lesen | |
| 23.07. | Fluent Corp: Fluent enters definitive agreement to sell N.Y. licence | 1 | Stockwatch | ||
| 23.07. | Fluent to sell New York cannabis operations to third party | 1 | Investing.com | ||
| 23.07. | FLUENT stößt New Yorker Cannabis-Sparte ab | 1 | Investing.com Deutsch | ||
| 23.07. | FLUENT Corp: FLUENT Announces Definitive Agreement to Sell New York License and Certain Operations | 334 | GlobeNewswire (Europe) | TAMPA, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced that it... ► Artikel lesen | |
| 18.07. | Fluent Corp: Fluent mails management information circular | 1 | Stockwatch | ||
| 18.07. | FLUENT Corp: FLUENT Provides Update and Supplemental Disclosure on Circular to Approve All-Stock Transaction With Vireo Growth Inc. | 538 | GlobeNewswire (Europe) | TORONTO, July 17, 2026 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, announces that, further to its... ► Artikel lesen | |
| 11.06. | Fluent Corp: Fluent interim CEO Vautrin resigns | 2 | Stockwatch | ||
| 11.06. | FLUENT appoints Matt Mundy as interim CEO as David Vautrin steps down | 1 | Seeking Alpha | ||
| 11.06. | FLUENT Corp: FLUENT Provides Management Update | 283 | GlobeNewswire (Europe) | TAMPA, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced that David... ► Artikel lesen | |
| 05.06. | FLUENT Corp. GAAP EPS of -$0.02, revenue of $17.89M | 1 | Seeking Alpha | ||
| 01.06. | FLUENT Corp: FLUENT Reports First Quarter 2026 Results | 224 | GlobeNewswire (Europe) | Q1 2026 Revenue of $17.9MEnded quarter with $8.3 million of cash and cash equivalentsReceived net proceeds of $5.7 million from interim financingContinued progress on Vireo transaction and Texas divestiture... ► Artikel lesen | |
| 13.05. | Fluent trims New York cannabis operations ahead of Vireo deal | 1 | Marijuana Business Daily | ||
| 02.05. | Fluent Corp: Fluent enters definitive deal to sell Cansortium Texas | 2 | Stockwatch | ||
| 01.05. | Fluent verkauft Cannabis-Geschäft in Texas für 30 Millionen US-Dollar | 2 | Investing.com Deutsch | ||
| 01.05. | Fluent to sell Texas cannabis operations for $30 million | 2 | Investing.com |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,448 | -1,15 % | Aurora Cannabis: Jetzt landet der Bieterkampf bei der Aufsicht | ||
| CANOPY GROWTH | 0,795 | +2,63 % | Canopy Growth Corporation: Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany | Mr. Blöte's appointment strengthens Canopy Growth's commercial leadership as it drives growth across its European medical cannabis businessCanopy Growth Corporation ("Canopy Growth", "our", "we" or... ► Artikel lesen | |
| TILRAY BRANDS | 3,200 | -0,16 % | Tilray Brands, Inc.: BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team | New appointments strengthen marketing, hospitality, category, and international commercial leadership as BrewDog advances long-term growth under Tilray BrandsELLON, Scotland and LONDON, Sept. 28, 2026... ► Artikel lesen | |
| INNOCAN PHARMA | 1,340 | +5,10 % | Innocan Pharma Corporation: VALITIC Expands Retail Industry Visibility Through Shoptalk Fall 2026 in Nashville, USA | HERZLIYA, Israel and CALGARY, Alberta, Sept. 29, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ("Innocan" or the "Company"), through B.I. Sky Global Ltd., its consumer... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -2- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameCA83013Q8719 CORE... ► Artikel lesen | |
| DERMAPHARM | 37,750 | -2,47 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen | |
| CRONOS GROUP | 2,818 | -1,67 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| SYNBIOTIC | 0,799 | -6,00 % | Original-Research: SYNBIOTIC SE (von NuWays AG): Under review | Original-Research: SYNBIOTIC SE - from NuWays AG
24.08.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for... ► Artikel lesen | |
| DIGICANN VENTURES | 0,008 | +7,14 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,837 | -1,06 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| GREEN THUMB INDUSTRIES | 6,010 | +1,69 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,126 | +1,81 % | Immortal Dragons: Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids" | SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem... ► Artikel lesen | |
| CRESCO LABS | 0,572 | -2,39 % | Cresco Labs Inc. - 6-K, Report of foreign issuer | ||
| NOVERIS HEALTH SCIENCES | 0,038 | -11,63 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces the results of its annual... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 2,924 | +0,07 % | Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target | TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of... ► Artikel lesen |
Das Unternehmen FLUENT CORP kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,020 Euro und damit -44,44 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FLUENT CORP finden Sie auf Wallstreet Online.